retatrutide clinical benefits Mazdutide vs retatrutide: dual agonist meets triple agonist in the next-gen weight loss showdown Results from retatrutide clinical trials?

Alcohol and other substance use disorders are common, and clinicians should be prepared to recognize them, just like hypertension and diabetes

Small clinical trials on GLP-1 drugs in younger age groups have shown bigger reductions in weight and BMI compared with existing treatments and common lifestyle interventions such as exercise and diet

And that's similar to cancer, actually, where you can do the genotype of an individual and identify what's the best chemotherapy or immunotherapy for an individual with, let's say, a certain kind of breast cancer

Treating obesity can be greatly beneficial for the prevention of CVD